EGFR and familial pancreatic carcinoma: CA19-9 itself can bind to the extracellular matrix, activate the epidermal growth factor receptor (EGFR) signaling pathway, and interact with the KrasG12D oncogene to promote pancreatic cancer growth [22, 23].